Abortion pill maker requests Supreme Court block on Fifth Circuit ruling restricting mifepristone mail access
On Saturday, Danco Laboratories and another drugmaker filed an emergency appeal to the Supreme Court seeking to overturn a Friday ruling by the Fifth Circuit Court of Appeals that banned mail-order access to mifepristone, the widely used abortion pill. The appellate decision required mifepristone to be distributed only in-person at clinics, overruling FDA regulations that permitted mail access. The Supreme Court request came in response to what abortion rights advocates describe as a major restriction on abortion access nationwide.
18
Divergence score
This event sits in the top 45% of divergence this week. 15 outlets covered it, splitting into 12 framing camps across 3 bias groups.
12 camps
3 bias groups
The spectrum · how 12 outlets placed this story
LeftCenterRight
PBS NewsHour
CNN
Reuters
Politico
Breitbart
Reason
NPR
New York Times
The Hill
ABC News
NY Post
Axios
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
The split, in one line
Coverage now splits sharply: conserv...
How each outlet covered it
What to know about a mifepristone maker asking the Supreme Court to restore access to the pill by mail
Appeals court blocks FDA rule that allows women to obtain abortion drugs by mail
Abortion pill makers ask US Supreme Court to restore mail-order access
Drugmakers file emergency appeal to restore abortion pill access
Fact ledger · what actually happened, cross-checked